359 related articles for article (PubMed ID: 32297065)
1. The role and molecular mechanism of epigenetics in cardiac hypertrophy.
Lei H; Hu J; Sun K; Xu D
Heart Fail Rev; 2021 Nov; 26(6):1505-1514. PubMed ID: 32297065
[TBL] [Abstract][Full Text] [Related]
2. Function of histone methylation and acetylation modifiers in cardiac hypertrophy.
Qin J; Guo N; Tong J; Wang Z
J Mol Cell Cardiol; 2021 Oct; 159():120-129. PubMed ID: 34175302
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics in cardiac development, function, and disease.
Nührenberg T; Gilsbach R; Preissl S; Schnick T; Hein L
Cell Tissue Res; 2014 Jun; 356(3):585-600. PubMed ID: 24817102
[TBL] [Abstract][Full Text] [Related]
4. Non-coding RNA-linked epigenetic regulation in cardiac hypertrophy.
Dong Y; Xu S; Liu J; Ponnusamy M; Zhao Y; Zhang Y; Wang Q; Li P; Wang K
Int J Biol Sci; 2018; 14(9):1133-1141. PubMed ID: 29989099
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure.
Greco CM; Condorelli G
Nat Rev Cardiol; 2015 Aug; 12(8):488-97. PubMed ID: 25962978
[TBL] [Abstract][Full Text] [Related]
6. Epigenetics in heart failure.
Papait R; Condorelli G
Ann N Y Acad Sci; 2010 Feb; 1188():159-64. PubMed ID: 20201899
[TBL] [Abstract][Full Text] [Related]
7. Impact of epigenetics in the management of cardiovascular disease: a review.
Cao Y; Lu L; Liu M; Li XC; Sun RR; Zheng Y; Zhang PY
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(20):3097-104. PubMed ID: 25392111
[TBL] [Abstract][Full Text] [Related]
8. Recent discoveries of the role of histone modifications and related inhibitors in pathological cardiac hypertrophy.
Wu KJ; Chen Q; Leung CH; Sun N; Gao F; Chen Z
Drug Discov Today; 2024 Feb; 29(2):103878. PubMed ID: 38211819
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis.
Watson CJ; Horgan S; Neary R; Glezeva N; Tea I; Corrigan N; McDonald K; Ledwidge M; Baugh J
J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):127-37. PubMed ID: 26130616
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy.
Papait R; Cattaneo P; Kunderfranco P; Greco C; Carullo P; Guffanti A; Viganò V; Stirparo GG; Latronico MV; Hasenfuss G; Chen J; Condorelli G
Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20164-9. PubMed ID: 24284169
[TBL] [Abstract][Full Text] [Related]
11. HOPX Plays a Critical Role in Antiretroviral Drugs Induced Epigenetic Modification and Cardiac Hypertrophy.
Kashyap S; Rabbani M; de Lima I; Kondrachuk O; Patel R; Shafiei MS; Mukker A; Rajakumar A; Gupta MK
Cells; 2021 Dec; 10(12):. PubMed ID: 34943964
[TBL] [Abstract][Full Text] [Related]
12. Epigenetics of Aberrant Cardiac Wound Healing.
Russell-Hallinan A; Watson CJ; Baugh JA
Compr Physiol; 2018 Mar; 8(2):451-491. PubMed ID: 29687888
[TBL] [Abstract][Full Text] [Related]
13. Roles of histone acetylation sites in cardiac hypertrophy and heart failure.
Funamoto M; Imanishi M; Tsuchiya K; Ikeda Y
Front Cardiovasc Med; 2023; 10():1133611. PubMed ID: 37008337
[TBL] [Abstract][Full Text] [Related]
14. Control of histone H3 phosphorylation by CaMKIIδ in response to haemodynamic cardiac stress.
Awad S; Al-Haffar KM; Marashly Q; Quijada P; Kunhi M; Al-Yacoub N; Wade FS; Mohammed SF; Al-Dayel F; Sutherland G; Assiri A; Sussman M; Bers D; Al-Habeeb W; Poizat C
J Pathol; 2015 Mar; 235(4):606-18. PubMed ID: 25421395
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic associations in relation to cardiovascular prevention and therapeutics.
Voelter-Mahlknecht S
Clin Epigenetics; 2016; 8():4. PubMed ID: 26779291
[TBL] [Abstract][Full Text] [Related]
16. Role of the Epigenome in Heart Failure.
Papait R; Serio S; Condorelli G
Physiol Rev; 2020 Oct; 100(4):1753-1777. PubMed ID: 32326823
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic-related therapeutic challenges in cardiovascular disease.
Schiano C; Vietri MT; Grimaldi V; Picascia A; De Pascale MR; Napoli C
Trends Pharmacol Sci; 2015 Apr; 36(4):226-35. PubMed ID: 25758254
[TBL] [Abstract][Full Text] [Related]
18. Epigenomic regulation of heart failure: integrating histone marks, long noncoding RNAs, and chromatin architecture.
McKinsey TA; Vondriska TM; Wang Y
F1000Res; 2018; 7():. PubMed ID: 30416708
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic Regulation in Atherosclerosis.
Wang C; Wang F; Liu F; Chen S
Discov Med; 2021; 31(162):45-49. PubMed ID: 34965371
[TBL] [Abstract][Full Text] [Related]
20. Pharmacoepigenetics in heart failure.
Mateo Leach I; van der Harst P; de Boer RA
Curr Heart Fail Rep; 2010 Jun; 7(2):83-90. PubMed ID: 20424992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
